Journal of Diabetes and Treatment
ISSN: 2574-7568
Impact Factor: 3.54
case report
![Dupilumab as a Novel and Effective Treatment for Refractory Necrobiosis Lipoidica](https://www.gavinpublishers.com/admin/assets/article_banner/1628309294article_image1181906454.jpg)
Dupilumab as a Novel and Effective Treatment for Refractory Necrobiosis Lipoidica
Allison Klos, Margareth Pierre-Louis*
Journal of Diabetes and Treatment